🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.
Salud Compra fuertePrecio actual
61,65 USD
Máx. histórico
2.925,00
12011 días
Split 1:10 del 17/11/2011
Caída desde máximo
-97,89%
Rango 52 semanas
37,06 – 95,49
Variación hoy
+3,56%
Cierre anterior
59,53
Rango de hoy
59,06 – 61,99
Volumen hoy
1.487.357
Peor caída histórica
-99,96%
16/12/1993 → 16/12/2016
Aún sin recuperar
Volatilidad anualizada ⓘ
231,86%
- Nombre completo
- Arrowhead Pharmaceuticals, Inc.
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 711
- PER ⓘ
- —
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 107,71 USD (puede no estar actualizado)
- Primera cotización
- 16/12/1993
- Precio actualizado
- hace 17 horas
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.
| Fecha | Ratio |
|---|---|
| 17/11/2011 | 1:10 |
| 15/01/2004 | 1:65 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 08/04/2010 | 12,20 | 12,90 | 11,40 | 11,70 | -3,31% | 12,30% | 98.870 |
| 07/04/2010 | 11,50 | 13,80 | 11,20 | 12,10 | +9,01% | 22,61% | 380.320 |
| 06/04/2010 | 10,60 | 11,30 | 10,60 | 11,10 | +1,83% | 6,60% | 40.090 |
| 05/04/2010 | 11,70 | 11,70 | 10,80 | 10,90 | -4,39% | 7,69% | 50.290 |
| 01/04/2010 | 11,90 | 11,90 | 11,00 | 11,40 | +0,00% | 7,56% | 66.110 |
| 31/03/2010 | 11,70 | 12,40 | 11,00 | 11,40 | -2,56% | 11,97% | 196.980 |
| 30/03/2010 | 9,30 | 11,70 | 8,72 | 11,70 | +23,16% | 32,04% | 355.680 |
| 29/03/2010 | 8,50 | 9,50 | 8,30 | 9,50 | +14,46% | 14,12% | 139.170 |
| 26/03/2010 | 9,40 | 9,44 | 8,11 | 8,30 | -10,46% | 14,15% | 185.710 |
| 25/03/2010 | 10,20 | 10,20 | 9,02 | 9,27 | -9,12% | 11,57% | 216.270 |
| 24/03/2010 | 10,30 | 10,70 | 9,66 | 10,20 | -10,53% | 10,10% | 457.910 |
| 23/03/2010 | 11,30 | 13,30 | 10,40 | 11,40 | +9,62% | 25,66% | 1.523.080 |
| 22/03/2010 | 6,30 | 12,80 | 6,20 | 10,40 | +92,59% | 104,76% | 2.566.290 |
| 19/03/2010 | 5,30 | 5,65 | 5,30 | 5,40 | +0,00% | 6,60% | 11.980 |
| 18/03/2010 | 5,50 | 5,65 | 5,30 | 5,40 | -1,82% | 6,36% | 7.050 |
| 17/03/2010 | 5,75 | 5,75 | 5,30 | 5,50 | -1,79% | 7,83% | 7.300 |
| 16/03/2010 | 5,60 | 5,60 | 5,23 | 5,60 | +3,70% | 6,61% | 9.610 |
| 15/03/2010 | 5,70 | 5,70 | 5,40 | 5,40 | +0,00% | 5,26% | 6.440 |
| 12/03/2010 | 5,40 | 5,50 | 5,30 | 5,40 | +0,00% | 3,70% | 5.300 |
| 11/03/2010 | 5,30 | 5,50 | 5,23 | 5,40 | +3,85% | 5,09% | 5.110 |
| 10/03/2010 | 5,20 | 5,50 | 5,20 | 5,20 | +0,00% | 5,77% | 9.750 |
| 09/03/2010 | 5,15 | 5,30 | 5,10 | 5,20 | -0,95% | 3,88% | 15.680 |
| 08/03/2010 | 5,10 | 5,60 | 5,10 | 5,25 | -0,94% | 9,80% | 3.270 |
| 05/03/2010 | 5,20 | 5,60 | 5,20 | 5,30 | +1,92% | 7,69% | 4.000 |
| 04/03/2010 | 5,60 | 5,60 | 5,20 | 5,20 | -1,89% | 7,14% | 3.770 |
| 03/03/2010 | 5,50 | 5,80 | 5,20 | 5,30 | -1,85% | 10,91% | 7.560 |
| 02/03/2010 | 5,10 | 5,50 | 5,00 | 5,40 | +5,88% | 9,80% | 17.510 |
| 01/03/2010 | 5,40 | 5,50 | 5,10 | 5,10 | -3,77% | 7,41% | 13.010 |
| 26/02/2010 | 5,50 | 5,60 | 5,30 | 5,30 | -3,64% | 5,45% | 8.080 |
| 25/02/2010 | 5,70 | 5,70 | 5,50 | 5,50 | -3,51% | 3,51% | 4.920 |